The 2014 vision of ALS Canada is “Within ten years, ALS will be a treatable disease.” To that end, ALS Canada's Strategic Plan for Research (2014-2017) established the goal to develop, through a national network, at least one novel therapeutic strategy to slow the progression of ALS. As a mechanism to achieve that goal, the Arthur J. Hudson Translational Team Grant has been established.
The discovery grant is for novel projects built around “high risk/potentially high impact” research. The clinical research fellowship supports specialized training in clinical care and research skills related to ALS.
ALS Canada established this fellowship in 2006 in honour of Tim E. Noël, former deputy governor of the Bank of Canada, who died of ALS in 2001. The fellowship is a partnership between ALS Canada and the CIHR’s INMHA; it recognizes and supports post-doctoral ALS researchers by awarding each recipient up to $55,000 annually for a maximum of three years. The aim of the fellowship is to encourage young scientists to pursue ALS research.
This is an initiative from ALS Canada, being run in partnership with the CIHR. The Griggs Fellowship provides three years of funding to a postdoctoral fellow through the generous support of Harvey and Sue Griggs of Toronto.
Awards created to support meritorious research for one year to position an investigator for reapplication to CIHR.
Research Funding History
CLICK HERE to view a table outlining the individuals funded by ALS Canada over the past seven years.